ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2022

Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients.

Rodrigo Pinheiro Araldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.